
|Videos|May 6, 2021
Looking at real-world trial data replication outcomes of AAO IRIS Registry data
Author(s)David Hutton, OTE Staff Reports
Dr Theodore Leng discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Advertisement
Dr Theodore Leng medical advisor at Verana Health and director of clinical translational research, Byers Eye Institute, Stanford University School of Medicine, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," in which the first replications using real-world data of a phase 3 trial was utilized, during the virtual 2021 ARVO meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
2
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
3
Mulling over options for mitigating severe vision loss from diabetes
4
AI-predicted retinal function shows promise in geographic atrophy
5

























